High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: evidence from outbreak investigation

Silvia D'Arezzo, Simone Lanini, Vincenzo Puro, Giuseppe Ippolito, Paolo Visca, Silvia D'Arezzo, Simone Lanini, Vincenzo Puro, Giuseppe Ippolito, Paolo Visca

Abstract

Background and methods: Pseudomonas aeruginosa is a major infectious threat to immunocompromised patients. We recently reported a fatal epidemic of multidrug-resistant P. aeruginosa in an onchoematology unit, linked to massive contamination of a triclosan-based disinfectant. The aim of this study is to evaluate the antimicrobial activity of triclosan and chlorhexidine digluconate against the epidemic strain of P. aeruginosa, to confirm the hypothesis that the soap dispenser acted as a continuous source of the infection during the outbreak, and to explore the potential role of triclosan in increasing the level of resistance to selected antibiotics.Susceptibility tests and time-kill assays for disinfectans were performed using two commercial formulations containing triclosan and chlorhexidine digluconate, respectively. Antibiotic susceptibility testing was performed by the broth microdilution method.

Findings: The P. aeruginosa epidemic strain exhibited an extremely high level of triclosan resistance (apparent MIC = 2,125 mg/L), while it was markedly susceptible to chlorhexidine digluconate (apparent MIC = 12.5 mg/L). Upon gradual adaptation to triclosan, the epidemic strain survived for a long period (> 120 h) in the presence of 3,400 mg/L (equivalent to 1.6 × MIC) of triclosan, concomitantly increasing the resistance to six antibiotics that are typical substrates of drug efflux pumps of the resistance nodulation division family. This effect was reversed by efflux pump inhibitors.

Conclusions: The epidemic P. aeruginosa strain was resistant to triclosan and its previous exposure to triclosan increases antibiotic resistance, likely through active efflux mechanisms. Since P. aeruginosa can become tolerant to elevated triclosan concentrations, the use of triclosan-based disinfectants should be avoided in those healthcare settings hosting patients at high risk for P. aeruginosa infection.

Figures

Figure 1
Figure 1
Time-kill kinetics of P. aeruginosa L2 in MH broth supplemented with chlorhexidine digluconate (product B, upper panel) or triclosan (product A, lower panel) at given concentrations.

References

    1. Kunz AN, Brook I. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy. 2010;56:492–500. doi: 10.1159/000321018.
    1. Engelhart S, Krizek L, Glasmacher A, Fischnaller E, Marklein G, Exner M. Pseudomonas aeruginos outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect. 2002;52:93–98. doi: 10.1053/jhin.2002.1279.
    1. Lanini S, D'Arezzo S, Puro V, Martini L, Imperi F, Piselli P, Montanaro M, Paoletti S, Visca P, Ippolito G. Molecular epidemiology of a hospital outbreak driven by a contaminated disinfectant-soap dispenser. PLoS One. 2011;6:e17064. doi: 10.1371/journal.pone.0017064.
    1. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147–179.
    1. Poole K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginos and related organisms. J Mol Microbiol Biotechnol. 2001;3:255–264.
    1. Zhu L, Lin J, Ma J, Cronan JE, Wang H. Triclosan resistance of Pseudomonas aeruginos PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase. Antimicrob Agents Chemother. 2010;54:689–698. doi: 10.1128/AAC.01152-09.
    1. Mima T, Joshi S, Gomez-Escalada M, Schweizer HP. Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginos requiring two membrane fusion proteins. J Bacteriol. 2007;189:7600–7609. doi: 10.1128/JB.00850-07.
    1. Schweizer HP. Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol Lett. 2001;202:1–7. doi: 10.1111/j.1574-6968.2001.tb10772.x.
    1. Walsh SE, Maillard JY, Russell AD, Catrenich CE, Charbonneau DL, Bartolo RG. Development of bacterial resistance to several biocides and effects on antibiotic susceptibility. J Hosp Infect. 2003;55:98–107. doi: 10.1016/S0195-6701(03)00240-8.
    1. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, Schweizer HP. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginos is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfx mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother. 2001;45:428–432. doi: 10.1128/AAC.45.2.428-432.2001.
    1. Grove C, Liebenberg W, du Preez JL, Yang W, de Villiers MM. Improving the aqueous solubility of triclosan by solubilization, complexation, and in situ salt formation. J Cosmet Sci. 2003;54:537–550.
    1. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing, twenty-first informational supplemen. Wayne: CLSI document M 100-S21; 2011.
    1. Orsi GB, Tomao P, Visca P. In vitro activity of commercially manufactured disinfectants against Pseudomonas aeruginos. Eur J Epidemiol. 1995;11:453–457. doi: 10.1007/BF01721232.
    1. Nakahara H, Kozukue H. Isolation of chlorhexidine-resistant Pseudomonas aeruginos from clinical lesions. J Clin Microbiol. 1982;15:166–168.
    1. Kampf G, Shaffer M, Hunte C. Insufficient neutralization in testing a chlorhexidine-containing ethanol-based hand rub can result in a false positive efficacy assessment. BMC Infect Dis. 2005;5:48. doi: 10.1186/1471-2334-5-48.
    1. Chuanchuen R, Karkhoff-Schweizer RR, Schweizer HP. High-level triclosan resistance in Pseudomonas aeruginos is solely a result of efflux. Am J Infect Control. 2003;31:124–127. doi: 10.1067/mic.2003.11.
    1. Bhargava HN, Leonard PA. Triclosan: applications and safety. Am J Infect Control. 1996;24:209–218. doi: 10.1016/S0196-6553(96)90017-6.

Source: PubMed

3
購読する